Lung Fibrosis after COVID-19: Treatment Prospects

“ILD” after COVID‐19 Infection: A Catalogue of Uncertainties

(2021) Athol U. Wells et al.   RADIOLOGY

Diffusion Capacity Abnormalities for Carbon Monoxide in Patients with COVID-19 At Three-Month Follow-up

(2021) Wei Qin et al.   EUROPEAN RESPIRATORY JOURNAL

Interstitial Lung Disease Following COVID-19

(2021) Vincent Cottin et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Inflammatory profiles and clinical features of COVID-19 survivors three months after discharge in Wuhan, China

(2021) Mei Zhou et al.   JOURNAL OF INFECTIOUS DISEASES

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

(2021) Xiaojun Wu et al.   Lancet Respiratory Medicine

The protective effect of Hederagenin on pulmonary fibrosis by regulating the Ras/JNK/NFAT4 axis in rats

(2020) Wenjing Ma et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Inhalation of Tetrandrine- hydroxypropyl-β-cyclodextrin Inclusion Complexes for Pulmonary Fibrosis Treatment

(2020) Wenqiang Su et al.   MOLECULAR PHARMACEUTICS

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the COVID-19 Pandemic

(2020) Alyson W. Wong et al.   CHEST

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

(2020) Ning Tang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

RECOVERY trial: the UK covid-19 study resetting expectations for clinical trials

(2020) Emma Wilkinson   BMJ-British Medical Journal

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

(2020) Peter M George et al.   Lancet Respiratory Medicine

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

(2020) Víctor J. Costela-Ruiz et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis

(2020) Marco Francone et al.   EUROPEAN RADIOLOGY

Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19

(2020) Margot Combet et al.   EUROPEAN RESPIRATORY JOURNAL

The progression of computed tomographic (CT) images in patients with coronavirus disease (COVID-19) pneumonia

(2020) Pinggui Lei et al.   JOURNAL OF INFECTION

COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases

(2020) Edy Ippolito et al.   RADIOTHERAPY AND ONCOLOGY

Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial

(2020) Chi Zhang et al.   Trials

Pulmonary fibrosis in the aftermath of the Covid-19 era (Review)

(2020) Eirini Vasarmidi et al.   Experimental and Therapeutic Medicine

CT features of COVID-19 patients with two consecutive negative RT-PCR tests after treatment

(2020) Zhao Fu et al.   Scientific Reports

Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19

(2020) Teluguakula Narasaraju et al.   Frontiers in Pharmacology

COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection

(2020) Kacper Lechowicz et al.   Journal of Clinical Medicine

Post-COVID-19 pneumonia pulmonary fibrosis

(2020) S Tale et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Healing after Covid-19: Are Survivors at Risk for Development of Pulmonary Fibrosis?

(2020) Lindsay T McDonald   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Post covid 19 pulmonary fibrosis. Is it real threat?

(2020) Deependra Kumar Rai et al.   Indian Journal of Tuberculosis

Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis

(2019) Rong Wu et al.   MOLECULES

Radiation-Induced Lung Injury

(2019) Alexander N. Hanania et al.   CHEST

Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells

(2019) Kim et al.   Biomolecules

Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes

(2018) Jens Markus Borghardt et al.   Canadian Respiratory Journal

Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose-derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis

(2018) Paschalis Ntolios et al.   Clinical Respiratory Journal

Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome

(2018) Wan Beom Park et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

c-Jun N-terminal kinase (JNK)-mediated induction of mSin1 expression and mTORC2 activation in mesenchymal cells during fibrosis

(2018) Natalie M. Walker et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Current approaches to the management of idiopathic pulmonary fibrosis

(2017) Ganesh Raghu et al.   RESPIRATORY MEDICINE

Effects of Pirfenidone and Collagen-Polyvinylpyrrolidone on Macroscopic and Microscopic Changes, TGF-β1 Expression, and Collagen Deposition in an Experimental Model of Tracheal Wound Healing

(2017) J. Raúl Olmos-Zuñiga et al.   Biomed Research International

Pirfenidone for the treatment of idiopathic pulmonary fibrosis

(2017) Peter M George et al.   Expert Review of Clinical Pharmacology

Common pathway signature in lung and liver fibrosis

(2016) Eugene Makarev et al.   CELL CYCLE

Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models

(2016) Wencheng Yu et al.   PHARMACEUTICAL BIOLOGY

Tetrandrine – A molecule of wide bioactivity

(2016) N. Bhagya et al.   PHYTOCHEMISTRY

Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy

(2016) Ting Liu et al.   Oncotarget

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

(2015) Lutz Wollin et al.   EUROPEAN RESPIRATORY JOURNAL

Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis

(2015) Shu Dong et al.   Evidence-based Complementary and Alternative Medicine

Increased Expression of Epidermal Growth Factor Receptor (EGF-R) in Patients with Different Forms of Lung Fibrosis

(2013) Argyris Tzouvelekis et al.   Biomed Research International

Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

(2011) Sharon Chao Wootton et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effect of anluohuaxian tablet combined with γ-IFN on schistosomal liver fibrosis

(2010) Jiaquan Huang et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status

(2010) Jenny C. NGAI et al.   RESPIROLOGY

Effects of genistein following fractionated lung irradiation in mice

(2009) Andrea E. Para et al.   RADIOTHERAPY AND ONCOLOGY